Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OM:EQT
OM:EQTCapital Markets

A Look At EQT (OM:EQT) Valuation After Recent Share Price Swings

Context for EQT shares after recent performance shifts EQT (OM:EQT) has drawn attention after a recent mix of short term gains and longer term setbacks, with the share price up over the past week and month but showing a decline over the past 3 months. See our latest analysis for EQT. With EQT shares at SEK296.2, the recent 1 month share price return of 6.05% contrasts with a 90 day share price decline of 17.72%, while the 1 year total shareholder return of 14.59% points to stronger longer...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Assessing PDF Solutions (PDFS) Valuation After Strong One Year Share Price Performance

Event context and recent share performance PDF Solutions (PDFS) has drawn attention after a recent move in its share price, with the stock last closing at US$40.66 and showing positive returns over the past week and month. Investors are also weighing the longer term picture, including a total 1 year return above 100% alongside relatively flat 3 year performance, as they reassess expectations for this semiconductor software and services provider. See our latest analysis for PDF Solutions. The...
TSE:1662
TSE:1662Oil and Gas

How Investors Are Reacting To Japan Petroleum Exploration (TSE:1662) As Oil Tops $100 On Gulf Tensions

Recently, failed US–Iran negotiations and the prospect of a US move to block the Strait of Hormuz pushed oil prices back above US$100, lifting many oil-related stocks including Japan Petroleum Exploration. This episode underlines how tightly Japan Petroleum Exploration’s outlook is tied to geopolitical flashpoints that can rapidly reshape global energy supply expectations. We will now examine how the jump in oil prices amid Middle East tensions may influence Japan Petroleum Exploration’s...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Assessing Harrow (HROW) Valuation As Heavy Insider Selling Tests The Undervaluation Story

Insider selling puts Harrow (HROW) under the microscope Heavy insider selling at Harrow (HROW) has caught investor attention after company insiders sold about US$8.1 million of stock over the past 3 months, with no reported insider purchases. This activity comes as Harrow shares recently fell 3.6% to US$35.93. At the same time, external models such as GuruFocus’s GF Value suggest the stock may be modestly undervalued, creating a tension between insider behavior and valuation signals. See our...
TSX:CURA
TSX:CURAPharmaceuticals

Curaleaf Holdings (TSX:CURA) Valuation Check After New Lorain Ohio Dispensary Opening

Why Curaleaf Holdings (TSX:CURA) Is In Focus After Its New Ohio Dispensary Opening Curaleaf Holdings (TSX:CURA) is back on investors radars after the company opened a new Curaleaf branded dispensary in Lorain, Ohio, adding to its presence in the state and across the United States. See our latest analysis for Curaleaf Holdings. At a share price of CA$3.32, Curaleaf’s 1 day share price return of 3.11% and 30 day share price return of 2.79% sit against a 1 year total shareholder return around...
XTRA:VRV
XTRA:VRVMedia

European Growth Stocks Insiders Are Eager To Own

As European markets rally following a U.S.-Iran ceasefire, with the STOXX Europe 600 Index climbing over 3%, investor sentiment appears to be cautiously optimistic despite looming economic uncertainties. In such an environment, growth companies with high insider ownership can be particularly appealing, as they often indicate confidence from those closest to the business and potential alignment of interests between management and shareholders.
WSE:DMG
WSE:DMGPersonal Products

European Penny Stocks To Watch In April 2026

Amid improving market sentiment in Europe, the pan-European STOXX Europe 600 Index saw a notable rise of 3.05% following a U.S.-Iran ceasefire agreement, boosting investor confidence across the region. As economic uncertainties linger with potential cuts to growth forecasts and mixed signals from various sectors, investors are increasingly seeking opportunities that balance risk and reward. While the term "penny stock" might seem outdated, it still points to smaller or newer companies that...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

Assessing ArcBest (ARCB) Valuation As Freight Indicators Point To Tighter Truckload Capacity

Why ArcBest Is Back on Freight Investors’ Radar Fresh data from Truist Securities pointing to tighter truckload capacity, higher load to truck ratios, and stronger national spot rates has refocused attention on ArcBest (ARCB) as freight conditions shift. See our latest analysis for ArcBest. ArcBest’s recent freight tailwinds have come alongside strong share price momentum, with a 30 day share price return of 27.91% and a 1 year total shareholder return of 74.95%. This may suggest that...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy (KOS) Is Down 15.5% After Goldman Sachs Flags Debt And Project Risks – Has The Bull Case Changed?

In early April 2026, Goldman Sachs downgraded Kosmos Energy from Neutral to Sell, citing concerns over its elevated debt levels and operational risks in key projects. This reassessment contrasts with recent operational momentum in Mauritania and Senegal, highlighting how financial structure and execution risk can influence analyst confidence even when production is improving. Next, we’ll examine how Goldman Sachs’ focus on Kosmos’s high debt burden may alter the company’s existing...
NYSE:BIRK
NYSE:BIRKLuxury

Is Birkenstock (BIRK) Turning Experiential Stores Like Bordeaux Into a Defensible Brand Moat?

Birkenstock Holding has expanded its European footprint by opening a new full-price store in Bordeaux, its 30th in the region, offering an immersive space where customers can experience its signature footbed and full product range; the location opened on March 31, 2026, with special events held on April 2. By framing the Bordeaux store as an experiential destination rather than a standard point of sale, Birkenstock is emphasizing brand engagement and product education as key elements of its...
DB:EIS
DB:EISMetals and Mining

Clínica Baviera And 2 Promising Small Caps To Explore In Europe

In the wake of a recent rally in European markets, spurred by geopolitical developments and positive sentiment, investors are turning their attention to small-cap stocks that may offer unique opportunities. As the pan-European STOXX Europe 600 Index shows signs of upward momentum, identifying promising small-cap companies like Clínica Baviera can be an intriguing endeavor for those seeking growth potential amidst evolving market conditions.
BME:CBAV
BME:CBAVHealthcare

Top 3 European Dividend Stocks To Consider

As European markets rally amid easing geopolitical tensions, investors are increasingly looking towards dividend stocks as a stable source of income in an uncertain economic environment. In light of recent market movements, a good dividend stock is often characterized by consistent payouts and the ability to weather economic fluctuations, making them an attractive option for those seeking reliable returns.
OM:NOLA B
OM:NOLA BIndustrials

Assessing Nolato (OM:NOLA B) Valuation After New CSRD Aligned Sustainability Report Publication

Sustainability reporting shift at Nolato (OM:NOLA B) Nolato (OM:NOLA B) has published its 2025 annual report, including a statutory sustainability report aligned with EU CSRD and ESRS standards. This provides ESG focused investors with more detailed insight into its Medical Solutions and Engineered Solutions operations. See our latest analysis for Nolato. The share price has recently picked up, with a 7 day share price return of 7.93% and a 30 day share price return of 4.53%. However, the 90...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

A Look At Bilibili (BILI) Valuation After AI Driven Upgrades From Citi And JPMorgan

Recent upgrades on Bilibili (BILI) by Citi and JPMorgan, tied to AI driven gains in advertising efficiency and user engagement, have pushed the stock back into focus for investors watching China’s online entertainment space. See our latest analysis for Bilibili. After a sharp pullback, reflected in a 30 day share price return of 2.90% and a 90 day share price return of 26.60%, stronger recent trading (including a 6.48% 7 day share price return) sits alongside a 45.83% 1 year total shareholder...
NYSE:LH
NYSE:LHHealthcare

CHOP Partnership On Specialized Pediatric Diagnostics Might Change The Case For Investing In Labcorp (LH)

On April 13, 2026, Children's Hospital of Philadelphia and Labcorp announced a collaboration to build a joint innovation pipeline that accelerates the discovery, development and nationwide rollout of specialized pediatric diagnostics across oncology, metabolic disease and autoimmune conditions. By tailoring diagnostics to children's distinct biology and pairing CHOP's research strength with Labcorp's national lab infrastructure, the partnership aims to make cutting-edge pediatric tests for...
NYSE:GPGI
NYSE:GPGITech

A Look At GPGI (GPGI) Valuation After Earnings Miss And Volatile Geopolitical Relief Rally

GPGI (GPGI) is back in focus after a relief rally tied to delayed U.S. military action in the Middle East faded, and attention shifted to its recent earnings and revenue shortfall. See our latest analysis for GPGI. That relief rally has now given way to renewed selling pressure, with the share price at US$16.39 and recent 7 day and 90 day share price returns of 5.04% and 23.52% declines. At the same time, 1 year and 3 year total shareholder returns of 53.26% and 169.35% point to a much...
NYSE:RERE
NYSE:RERESpecialty Retail

Assessing ATRenew (RERE) Valuation As AI Model Downgrade Highlights Cash Flow And Margin Concerns

ATRenew (RERE) is back in focus after AI driven models downgraded the stock, citing negative operating cash flow, compressed gross margins, weak technical signals, and a valuation that appears elevated relative to current profitability. See our latest analysis for ATRenew. Despite the downgrade, ATRenew’s recent 1 day share price return of 5.38% to US$4.70 and 7 day share price return of 5.15% sit against a weaker 30 and 90 day share price trend. At the same time, the 1 year total shareholder...
NYSE:ICL
NYSE:ICLChemicals

How Investors May Respond To ICL Group (ICL) Q1 Beat And Fertilizer Price Stabilization

In the past few days, ICL Group reported stronger-than-expected first-quarter 2024 results, with its specialty minerals segment outperforming and broader fertilizer markets showing signs of potash and phosphate price stabilization. This combination of operational outperformance and easing commodity price pressure has reinforced investor confidence in the company’s recovery prospects amid ongoing geopolitical supply concerns. We’ll now examine how this earnings beat, particularly in specialty...
SHSE:688599
SHSE:688599Semiconductor

Asian Growth Companies With High Insider Ownership Expecting Up To 109% Earnings Growth

As global markets react to geopolitical developments, including a recent U.S.-Iran ceasefire that has improved investor sentiment and eased oil price pressures, the Asian markets are also experiencing shifts in investment dynamics. In this context, companies with high insider ownership and strong growth prospects can be particularly appealing to investors seeking stability and potential upside in an uncertain environment.
SZSE:002397
SZSE:002397Luxury

Shenzhen Hemei GroupLTD Leads The Charge In Asian Penny Stock Highlights

As global markets experience a renewed optimism following the U.S.-Iran ceasefire agreement, investor sentiment has improved significantly, with major indices in Asia reflecting this positive shift. This environment provides a backdrop for exploring investment opportunities beyond the mainstream, particularly in penny stocks—an area that continues to intrigue investors due to its potential for significant returns. While the term "penny stocks" may seem outdated, these smaller or newer...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Cimpress (CMPR) Is Up 6.0% After Authorizing US$200 Million Buyback Plan Has The Bull Case Changed?

Cimpress plc recently announced a share repurchase program authorizing the company to buy back up to US$200 million of its own stock. This sizeable authorization highlights management’s willingness to deploy capital toward reducing the share count, which can influence future earnings per share calculations. Next, we’ll explore how this US$200 million buyback plan might reshape Cimpress’ investment narrative and capital allocation outlook. AI is about to change healthcare. These 34 stocks are...